Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Aug 24 | MORF Morphic Holding | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 30.52 | 23,168 | 707.09 k | 0 |
16 Aug 24 | MORF Morphic Holding | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 56.47 | 12,535 | 707.85 k | 0 |
16 Aug 24 | MORF Morphic Holding | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 24.49 | 17,550 | 429.80 k | 0 |
16 Aug 24 | MORF Morphic Holding | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 55.46 | 18,111 | 1.00 mm | 0 |
4 Jun 24 | MORF Morphic Holding | Common Stock Common Stock | Grant | Acquire A | No | No | 30.52 | 23,168 | 707.09 k | 23,168 |
23 May 24 | MRVI Maravai LifeSciences | Class A Common Stock | Grant | Acquire A | No | No | 10.78 | 20,645 | 222.55 k | 80,768 |
21 May 24 | FDMT 4D Molecular Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 25.15 | 22,500 | 565.88 k | 22,500 |
8 May 24 | TBPH Theravance Biopharma | Ordinary Shares | Grant | Acquire A | No | No | 0 | 10,537 | 0.00 | 31,488 |
8 May 24 | TBPH Theravance Biopharma | Share Option Ordinary Shares | Grant | Acquire A | No | No | 9.49 | 23,576 | 223.74 k | 23,576 |